Literature DB >> 8962139

Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy.

B Hess1, P Saftig, D Hartmann, R Coenen, R Lüllmann-Rauch, H H Goebel, M Evers, K von Figura, R D'Hooge, G Nagels, P De Deyn, C Peters, V Gieselmann.   

Abstract

Metachromatic leukodystrophy is a lysosomal sphingolipid storage disorder caused by the deficiency of arylsulfatase A. The disease is characterized by progressive demyelination, causing various neurologic symptoms. Since no naturally occurring animal model of the disease is available, we have generated arylsulfatase A-deficient mice. Deficient animals store the sphingolipid cerebroside-3-sulfate in various neuronal and nonneuronal tissues. The storage pattern is comparable to that of affected humans, but gross defects of white matter were not observed up to the age of 2 years. A reduction of axonal cross-sectional area and an astrogliosis were observed in 1-year-old mice; activation of microglia started at 1 year and was generalized at 2 years. Purkinje cell dendrites show an altered morphology. In the acoustic ganglion numbers of neurons and myelinated fibers are severely decreased, which is accompanied by a loss of brainstem auditory-evoked potentials. Neurologic examination reveals significant impairment of neuromotor coordination.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8962139      PMCID: PMC26220          DOI: 10.1073/pnas.93.25.14821

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease.

Authors:  P Leinekugel; S Michel; E Conzelmann; K Sandhoff
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

2.  Molecular basis of different forms of metachromatic leukodystrophy.

Authors:  A Polten; A L Fluharty; C B Fluharty; J Kappler; K von Figura; V Gieselmann
Journal:  N Engl J Med       Date:  1991-01-03       Impact factor: 91.245

3.  High residual arylsulfatase A (ARSA) activity in a patient with late-infantile metachromatic leukodystrophy.

Authors:  J Kreysing; W Bohne; C Bösenberg; S Marchesini; J C Turpin; N Baumann; K von Figura; V Gieselmann
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

4.  Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease.

Authors:  S Yamanaka; M D Johnson; A Grinberg; H Westphal; J N Crawley; M Taniike; K Suzuki; R L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

5.  Structure of the mouse arylsulfatase A gene and cDNA.

Authors:  J Kreysing; A Polten; B Hess; K von Figura; K Menz; F Steiner; V Gieselmann
Journal:  Genomics       Date:  1994-01-15       Impact factor: 5.736

6.  A neutral galactocerebroside sulfate sulfatidase from mouse brain.

Authors:  S K Sundaram; J H Fan; M Lev
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

7.  Lysosulfatide (sulfogalactosylsphingosine) accumulation in tissues from patients with metachromatic leukodystrophy.

Authors:  K Toda; T Kobayashi; I Goto; K Ohno; Y Eto; K Inui; S Okada
Journal:  J Neurochem       Date:  1990-11       Impact factor: 5.372

8.  Functional compartments of sulphatide metabolism in cultured living cells: evidence for the involvement of a novel sulphatide-degrading pathway.

Authors:  M C Tempesta; R Salvayre; T Levade
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

Review 9.  Molecular genetics of metachromatic leukodystrophy.

Authors:  V Gieselmann; J Zlotogora; A Harris; D A Wenger; C P Morris
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

10.  Targeted disruption of the M(r) 46,000 mannose 6-phosphate receptor gene in mice results in misrouting of lysosomal proteins.

Authors:  A Köster; P Saftig; U Matzner; K von Figura; C Peters; R Pohlmann
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

View more
  66 in total

1.  4th Symposium on Probing Disorders of the White Matter. Abstracts.

Authors: 
Journal:  J Mol Neurosci       Date:  1999-06       Impact factor: 3.444

Review 2.  Gene transfer approaches to the lysosomal storage disorders.

Authors:  J A Barranger; E O Rice; W P Swaney
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

3.  Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice.

Authors:  Françoise Piguet; Dolan Sondhi; Monique Piraud; Françoise Fouquet; Neil R Hackett; Ornella Ahouansou; Marie-Thérèse Vanier; Ivan Bieche; Patrick Aubourg; Ronald G Crystal; Nathalie Cartier; Caroline Sevin
Journal:  Hum Gene Ther       Date:  2012-07-23       Impact factor: 5.695

Review 4.  Development of gene therapy for blood disorders: an update.

Authors:  Arthur W Nienhuis
Journal:  Blood       Date:  2013-07-10       Impact factor: 22.113

Review 5.  Gene therapy for metachromatic leukodystrophy.

Authors:  Jonathan B Rosenberg; Stephen M Kaminsky; Patrick Aubourg; Ronald G Crystal; Dolan Sondhi
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

6.  Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy.

Authors:  Ulrich Matzner; Renate Lüllmann-Rauch; Stijn Stroobants; Claes Andersson; Cecilia Weigelt; Carl Eistrup; Jens Fogh; Rudi D'Hooge; Volkmar Gieselmann
Journal:  Mol Ther       Date:  2009-01-27       Impact factor: 11.454

Review 7.  Metachromatic leukodystrophy: molecular genetics and an animal model.

Authors:  V Gieselmann; U Matzner; B Hess; R Lüllmann-Rauch; R Coenen; D Hartmann; R D'Hooge; P DeDeyn; G Nagels
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

Review 8.  Properties, metabolism and roles of sulfogalactosylglycerolipid in male reproduction.

Authors:  Nongnuj Tanphaichitr; Kessiri Kongmanas; Kym F Faull; Julian Whitelegge; Federica Compostella; Naoko Goto-Inoue; James-Jules Linton; Brendon Doyle; Richard Oko; Hongbin Xu; Luigi Panza; Arpornrad Saewu
Journal:  Prog Lipid Res       Date:  2018-08-25       Impact factor: 16.195

9.  Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiation.

Authors:  Fiona L Wilkinson; Ana Sergijenko; Kia J Langford-Smith; Marcela Malinowska; Rob F Wynn; Brian W Bigger
Journal:  Mol Ther       Date:  2013-02-19       Impact factor: 11.454

10.  Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB.

Authors:  Kazuhiro Ohmi; David S Greenberg; Kavitha S Rajavel; Sergey Ryazantsev; Hong Hua Li; Elizabeth F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.